Berkshire Hathaway Inc.
a greater than 5% beneficial owner of Occidental’s common stock
Approximately $9.7 billion
Purchase and sale agreement under which Berkshire agreed to acquire all issued and outstanding equity interests in OxyChem in an all-cash transaction, subject to customary purchase price adjustments; the transaction closed January 2, 2026.
With Occidental
Open in proxy
